Skip to content

Target Organ Damage in Patients With Repaired Coarctation of Aorta and Exercise Induced Hypertension

Target Organ Damage in Patients With Repaired Coarctation of Aorta and Exercise Induced Hypertension

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07134621
Enrollment
50
Registered
2025-08-21
Start date
2025-07-16
Completion date
2026-08-01
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coarctation of the Aorta

Brief summary

The goal of this observational study is to obtain data on the effect of exercise induced hypertension on target organs in adult patients with repaired coarctation of the aorta. The main questions it aims to answer are: * patients with exercise induced hypertension have signs of hypertensive heart disease? * patients with exercise induced hypertension have increased arterial stiffness? * patients with exercise induced hypertension have signs of hypertensive renal damage? Participants will be invited for an outpatient appointment during which medical history and physical investigation will be performed. They will undergo cardiopulmonary exercise testing during which blood pressure will be measured regularly. Transthoracic echocardiography will also be performed as well as assessment of arterial stiffness by measuring pulse wave velocity. Renal function will be assessed by blood and urine analysis.

Interventions

None listed

Sponsors

University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients aged 18 years and older * history of coarctation of aorta repair

Exclusion criteria

* haemodynamically significant recoarctation * arterial hypertension at rest * antihypertensive therapy * associated haemodynamically significant valvular heart disease * associated complex congenital heart disease * advanced heart failure * symptomatic arrhythmias * cognitive or physical limitations to perform exercise stress testing

Design outcomes

Primary

MeasureTime frame
Number of patients with EIH who also have signs of hypertensive heart disease.At enrolment.
Number of patients with EIH and increased arterial stiffness.At enrolment.
Number of patients with EIH and signs of hypertensive renal damage.At enrolment.

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026